Trades on 1 secondary market

Atomic Ai

Atomic AI is a biotechnology company fusing machine learning with structural biology to unlock RNA drug discovery. Founded in 2017 by Raphael Townshend and based in San Francisco, the company builds ATOM-1, an AI foundation model that predicts the three-dimensional structure of RNA to enable the dis

minimal 11.2 / 100 0 APIs View provider profile →

Company Deep Tech Biotechnology Drug Discovery RNA Machine Learning

Atomic Ai is an API provider whose private shares are listed on 1 secondary market: EquityZen.

Where It Trades

EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.